3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
14
Prostatic Neoplasms
4
Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Precancerous Conditions
2
Peripheral Nervous System Diseases
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Breast Carcinoma In Situ
2
Weight Loss
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Polycystic Ovary Syndrome
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Interventions
Etanercept
12
Adalimumab
12
Infliximab
7
golimumab
4
Tumor Necrosis Factor Inhibitors
4
Certolizumab Pegol
4
Abatacept
4
tofacitinib
2
tocilizumab
2
Rituximab
2
Antirheumatic Agents
2
Vitamin D
1
Vaccines
1
Syringes
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Radioimmunodetection
1
Prednisone
1
Practice Guidelines as Topic
1
Phlebotomy
1
Observation
1
Nivolumab
1
Methotrexate
1
Methods
1
Lysine Acetyltransferase 5
1
Licensure
1
Leflunomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis, Rheumatoid
×
Fatty Acids, Omega-3
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts